Albemarle Co. (NYSE:ALB)’s share price gapped down before the market opened on Friday after Jefferies Group lowered their price target on the stock to $150.00. The stock had previously closed at $138.70, but opened at $126.95. Jefferies Group currently has a buy rating on the stock. Albemarle shares last traded at $117.91, with a volume of 8622300 shares trading hands.
ALB has been the subject of several other research reports. Robert W. Baird reaffirmed a “hold” rating and set a $135.00 price target on shares of Albemarle in a research report on Wednesday, November 1st. Nomura upped their price target on shares of Albemarle from $146.00 to $154.00 and gave the company a “buy” rating in a research report on Tuesday, October 10th. Royal Bank of Canada reaffirmed a “buy” rating and set a $149.00 price target on shares of Albemarle in a research report on Wednesday, October 18th. Oppenheimer reaffirmed a “buy” rating on shares of Albemarle in a research report on Wednesday. Finally, Deutsche Bank lowered shares of Albemarle from a “buy” rating to a “hold” rating in a research report on Tuesday, November 14th. Ten analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Albemarle currently has a consensus rating of “Buy” and a consensus price target of $127.78.
A number of institutional investors have recently added to or reduced their stakes in ALB. Northwestern Mutual Wealth Management Co. increased its holdings in Albemarle by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 20 shares in the last quarter. Thompson Davis & CO. Inc. increased its holdings in Albemarle by 650.0% in the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 650 shares in the last quarter. Highlander Capital Management LLC purchased a new stake in Albemarle in the 2nd quarter worth approximately $106,000. Advisory Services Network LLC increased its holdings in Albemarle by 43.7% in the 2nd quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock worth $134,000 after acquiring an additional 387 shares in the last quarter. Finally, Howe & Rusling Inc. increased its holdings in Albemarle by 2,038.0% in the 3rd quarter. Howe & Rusling Inc. now owns 1,069 shares of the specialty chemicals company’s stock worth $146,000 after acquiring an additional 1,019 shares in the last quarter. 88.07% of the stock is owned by institutional investors.
Albemarle (NYSE:ALB) last announced its quarterly earnings data on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.01. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The business had revenue of $755.00 million during the quarter, compared to analyst estimates of $732.19 million. During the same period last year, the firm posted $0.91 EPS. The company’s revenue was up 15.4% on a year-over-year basis. equities research analysts predict that Albemarle Co. will post 4.46 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is currently 45.71%.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://weekherald.com/2018/01/20/albemarle-alb-shares-gap-down-after-analyst-downgrade.html.
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.